TP53 and cancer: In summary, this is the first report that DPEITC, a synthetic ITC, inhibits the growth of TNBC cancer cells harboring different “hotspot” p53 mutants (structural and contact) via mutant p53 rescue and is a more potent inhibitor than the naturally occurring dietary-related PEITC.